ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Prostaglandins &Other Lipid Mediators
Volume 78, Issues 1-4, December 2005, Pages 38-45
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (108 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.prostaglandins.2005.02.003    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2005 Elsevier Inc. All rights reserved.

Influence of a prostaglandin synthesis inhibitor administered at embryo transfer on pregnancy rates of recipient cows

F.N. Scennaa, M.E. Hocketta, T.M. Townsa, A.M. Saxtona, N.R. Rohrbacha, M.E. Wehrmanb and F.N. Schricka, Corresponding Author Contact Information, E-mail The Corresponding Author

aDepartment of Animal Science, University of Tennessee, 205 C Brehm Animal Science Building, Knoxville, TN 37996-4574, USA bRocky Mountain Reproductive Services, Inc., Manhattan, MT, USA

Received 30 December 2004; 
revised 12 February 2005; 
accepted 19 February 2005. 
Available online 3 June 2005.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Elevated uterine luminal concentrations of prostaglandin F (PGF) have been negatively associated with embryo quality and pregnancy rates. Two studies were performed in cows to determine PGF release from uterine endometrium following embryo transfer and to investigate administration of flunixin meglumine (FM), a prostaglandin synthesis inhibitor, on pregnancy rates following embryo transfer. In Experiment 1, blood samples were collected prior to and after embryo transfer from the posterior vena cava via saphenous vein cannulation. Serum profiles of PGF indicated that manipulation of the reproductive tract during embryo transfer was followed by increased release of PGF from the uterine endometrium. In Experiment 2, estrus (day = 0) was synchronized in recipient animals and a single embryo transferred 7 days after estrus. At the time of non-surgical embryo transfer, animals were randomly assigned to receive either FM (FM; n = 1300) or remain untreated (control (CON); n = 797). Data collected at transfer included stage of embryo development, embryo quality, technician, and transfer quality score. Overall pregnancy rates of cows receiving FM (65%) were higher than control cows (60%; P < 0.02). Pregnancy rates following transfer of quality 1 (good) embryos did not differ (P > 0.05) between treatments. However, pregnancy rates of quality 2 (fair) embryos were higher in animals receiving FM than in CON (P < 0.01). Moreover, pregnancy rates of transferred morula- and blastocyst-stage embryos were higher in FM-treated than in controls (P < 0.06 and P < 0.04, respectively). In conclusion, uterine release of PGF is elevated following embryo transfer and administration of a PGF synthesis inhibitor at the time of embryo transfer improved pregnancy rates in cows.

Keywords: Prostaglandin; Pregnancy rates; Cow; Embryo transfer

Article Outline

1. Introduction
2. Materials and methods
2.1. Experiment 1
2.2. Experiment 2
3. Results and discussion
Acknowledgements
References


 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.